Immunity against Human Papillomavirus (HPV) in vaccinated and non-vaccinated probands

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005278

Enrollment

Registered

2013-09-13

Start date

2013-10-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune response after HPV vaccination Healthy Volunteer

Interventions

Group 1: Blood is taken from healthy probands, which are vaccinated against HPV with one of the licensed vaccines. The specific reactivity of freshly isolated lymphocytes against HPV 16 E6 and E7 is t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: either vaccinated against HPV or no HPV vaccination

Exclusion criteria

Exclusion criteria: pregnancy and diseases that influence the immune system, e.g. autoimmune diseases or infections

Design outcomes

Primary

Measure	Time frame
Interferon-gamma production of freshly isolated lymphocytes within 2 days by ELISpot.	—

Countries

Germany

Contacts

Public ContactMonika Lindemann

Universitätsklinikum Essen, Institut für Transfusionsmedizin

monika.lindemann@uk-essen.de0201-7234217

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026